Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata

Candida glabrata is a leading cause of invasive candidiasis. In contrast to other species, it has a high propensity for developing resistance to echinocandins, which are the first-line treatment. ABSTRACT Here, we report two paired sets of an index wild-type Candida glabrata bloodstream isolate and subsequent echinocandin-resistant FKS mutant. One paired set exhibited a higher proportion of clumping cells and was more virulent in the invertebrate host Galleria mellonella than the other paired set. No virulence difference between the paired index and FKS strains was observed. These findings imply a potential link of clumping morphology with virulence in C. glabrata that is uncoupled from FKS-mediated echinocandin resistance. IMPORTANCE Candida glabrata is a leading cause of invasive candidiasis. In contrast to other species, it has a high propensity for developing resistance to echinocandins, which are the first-line treatment. Unlike the dimorphic Candida albicans which can grow invasive filamentous hyphae, C. glabrata lacks this ability. Here, we report a link between virulence and clumping cell morphology in two different sets of clinical C. glabrata strains obtained from patients failing echinocandin therapy. One set of paired strains (echinocandin-susceptible and subsequent resistant mutant) had a high proportion of clumping cells in the population and were significantly more virulent than another set which had fewer clumping cells. Additionally, we corroborate that echinocandin resistance does not impart a significant fitness cost. Our findings suggest that clumping morphology may be an important but previously underestimated virulence factor for C. glabrata and also aid our understand for the high prevalence of resistance observed in this species.

[1]  G. Balázsi,et al.  Disadvantages and benefits of evolved unicellularity versus multicellularity in budding yeast , 2019, Ecology and evolution.

[2]  A. Borman,et al.  Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species , 2016, mSphere.

[3]  K. Garey,et al.  Innate Inflammatory Response and Immunopharmacologic Activity of Micafungin, Caspofungin, and Voriconazole against Wild-Type and FKS Mutant Candida glabrata Isolates , 2015, Antimicrobial Agents and Chemotherapy.

[4]  D. Kontoyiannis,et al.  Drug-Resistant Candida glabrata Infection in Cancer Patients , 2014, Emerging infectious diseases.

[5]  S. Brunke,et al.  One Small Step for a Yeast - Microevolution within Macrophages Renders Candida glabrata Hypervirulent Due to a Single Point Mutation , 2014, PLoS pathogens.

[6]  K. Garey,et al.  FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Andreoni,et al.  Antifungal resistance does not necessarily affect Candida glabrata fitness , 2014, Journal of chemotherapy.

[8]  B. Wickes,et al.  Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure , 2013, Antimicrobial Agents and Chemotherapy.

[9]  M. Castanheira,et al.  Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Gow,et al.  Differential Virulence of Candida glabrata Glycosylation Mutants , 2013, The Journal of Biological Chemistry.

[11]  S. Costa-de-Oliveira,et al.  Determination of chitin content in fungal cell wall: An alternative flow cytometric method , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[12]  D. Kontoyiannis,et al.  Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. , 2011, The Journal of infectious diseases.

[13]  Ronald N. Jones,et al.  Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains , 2010, Antimicrobial Agents and Chemotherapy.

[14]  J. Cleary,et al.  Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint , 2009, Antimicrobial Agents and Chemotherapy.

[15]  G. Butler,et al.  Inactivation of Transcription Factor Gene ACE2 in the Fungal Pathogen Candida glabrata Results in Hypervirulence , 2004, Eukaryotic Cell.